Carrick Therapeutics raises $60m for novel cancer treatments
The Dublin commence-up elevated $25m in a Collection C round and secured $35m from Pfizer
Carrick
The Dublin commence-up elevated $25m in a Collection C round and secured $35m from Pfizer